The global Age Related Macular Degeneration Drug market size was valued at USD 7949.4 million in 2023 and is forecast to a readjusted size of USD 11680 million by 2030 with a CAGR of 5.6% during review period.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
The report includes an overview of the development of the Age Related Macular Degeneration Drug industry chain, the market status of Hospitals (Lucentis, Eylea), Clinics (Lucentis, Eylea), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Age Related Macular Degeneration Drug.
Regionally, the report analyzes the Age Related Macular Degeneration Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Age Related Macular Degeneration Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Age Related Macular Degeneration Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Age Related Macular Degeneration Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Lucentis, Eylea).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Age Related Macular Degeneration Drug market.
Regional Analysis: The report involves examining the Age Related Macular Degeneration Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Age Related Macular Degeneration Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Age Related Macular Degeneration Drug:
Company Analysis: Report covers individual Age Related Macular Degeneration Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Age Related Macular Degeneration Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Age Related Macular Degeneration Drug. It assesses the current state, advancements, and potential future developments in Age Related Macular Degeneration Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Age Related Macular Degeneration Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Age Related Macular Degeneration Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Lucentis
Eylea
Avastin
Others
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Age Related Macular Degeneration Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Age Related Macular Degeneration Drug, with price, sales, revenue and global market share of Age Related Macular Degeneration Drug from 2019 to 2024.
Chapter 3, the Age Related Macular Degeneration Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Age Related Macular Degeneration Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Age Related Macular Degeneration Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Age Related Macular Degeneration Drug.
Chapter 14 and 15, to describe Age Related Macular Degeneration Drug sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Age Related Macular Degeneration Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Lucentis
1.3.3 Eylea
1.3.4 Avastin
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Age Related Macular Degeneration Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Age Related Macular Degeneration Drug Market Size & Forecast
1.5.1 Global Age Related Macular Degeneration Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Age Related Macular Degeneration Drug Sales Quantity (2019-2030)
1.5.3 Global Age Related Macular Degeneration Drug Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals
2.1.1 Regeneron Pharmaceuticals Details
2.1.2 Regeneron Pharmaceuticals Major Business
2.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product and Services
2.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
2.2 Bayer HealthCare
2.2.1 Bayer HealthCare Details
2.2.2 Bayer HealthCare Major Business
2.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Product and Services
2.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer HealthCare Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Age Related Macular Degeneration Drug Product and Services
2.3.4 Novartis Age Related Macular Degeneration Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Age Related Macular Degeneration Drug Product and Services
2.4.4 Roche Age Related Macular Degeneration Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Roche Recent Developments/Updates
2.5 Kanghong Pharma
2.5.1 Kanghong Pharma Details
2.5.2 Kanghong Pharma Major Business
2.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Product and Services
2.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kanghong Pharma Recent Developments/Updates
3 Competitive Environment: Age Related Macular Degeneration Drug by Manufacturer
3.1 Global Age Related Macular Degeneration Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Age Related Macular Degeneration Drug Revenue by Manufacturer (2019-2024)
3.3 Global Age Related Macular Degeneration Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Age Related Macular Degeneration Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Age Related Macular Degeneration Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Age Related Macular Degeneration Drug Manufacturer Market Share in 2023
3.5 Age Related Macular Degeneration Drug Market: Overall Company Footprint Analysis
3.5.1 Age Related Macular Degeneration Drug Market: Region Footprint
3.5.2 Age Related Macular Degeneration Drug Market: Company Product Type Footprint
3.5.3 Age Related Macular Degeneration Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Age Related Macular Degeneration Drug Market Size by Region
4.1.1 Global Age Related Macular Degeneration Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Age Related Macular Degeneration Drug Consumption Value by Region (2019-2030)
4.1.3 Global Age Related Macular Degeneration Drug Average Price by Region (2019-2030)
4.2 North America Age Related Macular Degeneration Drug Consumption Value (2019-2030)
4.3 Europe Age Related Macular Degeneration Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Age Related Macular Degeneration Drug Consumption Value (2019-2030)
4.5 South America Age Related Macular Degeneration Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Age Related Macular Degeneration Drug Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
5.2 Global Age Related Macular Degeneration Drug Consumption Value by Type (2019-2030)
5.3 Global Age Related Macular Degeneration Drug Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
6.2 Global Age Related Macular Degeneration Drug Consumption Value by Application (2019-2030)
6.3 Global Age Related Macular Degeneration Drug Average Price by Application (2019-2030)
7 North America
7.1 North America Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
7.2 North America Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
7.3 North America Age Related Macular Degeneration Drug Market Size by Country
7.3.1 North America Age Related Macular Degeneration Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Age Related Macular Degeneration Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
8.2 Europe Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
8.3 Europe Age Related Macular Degeneration Drug Market Size by Country
8.3.1 Europe Age Related Macular Degeneration Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Age Related Macular Degeneration Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Age Related Macular Degeneration Drug Market Size by Region
9.3.1 Asia-Pacific Age Related Macular Degeneration Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Age Related Macular Degeneration Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
10.2 South America Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
10.3 South America Age Related Macular Degeneration Drug Market Size by Country
10.3.1 South America Age Related Macular Degeneration Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Age Related Macular Degeneration Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Age Related Macular Degeneration Drug Market Size by Country
11.3.1 Middle East & Africa Age Related Macular Degeneration Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Age Related Macular Degeneration Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Age Related Macular Degeneration Drug Market Drivers
12.2 Age Related Macular Degeneration Drug Market Restraints
12.3 Age Related Macular Degeneration Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Age Related Macular Degeneration Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Age Related Macular Degeneration Drug
13.3 Age Related Macular Degeneration Drug Production Process
13.4 Age Related Macular Degeneration Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Age Related Macular Degeneration Drug Typical Distributors
14.3 Age Related Macular Degeneration Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
*If Applicable.